CDA and neoplasm: Within PDAC tumor environments, Gammaproteobacteria can metabolize gemcitabine into the non-active form 2′, 2′-difluoro deoxyuridine through the enzymatic action of cytidine deaminase, thus reducing its efficacy against cancer.